Follow
Lamyaa Mohammed Kamal
Lamyaa Mohammed Kamal
consultant of clinical & chemical pathology at GOTHI
Verified email at egycdc.com
Title
Cited by
Cited by
Year
Predictors of severity and development of critical illness of Egyptian COVID-19 patients: A multicenter study
D Omran, M Al Soda, E Bahbah, G Esmat, H Shousha, A Elgebaly, ...
Plos one 16 (9), e0256203, 2021
312021
Prediction of mortality in hospitalized Egyptian patients with Coronavirus disease-2019: A multicenter retrospective study
MM AbdelGhaffar, D Omran, A Elgebaly, EI Bahbah, S Afify, M AlSoda, ...
Plos one 17 (1), e0262348, 2022
222022
HLA-B* 15 predicts survival in Egyptian patients with COVID-19
AS Abdelhafiz, A Ali, MA Fouda, DM Sayed, MM Kamel, LM Kamal, ...
Human Immunology 83 (1), 10-16, 2022
182022
Upregulation of FOXP3 is associated with severity of hypoxia and poor outcomes in COVID-19 patients
AS Abdelhafiz, MA Fouad, MM Sayed-Ahmed, MM Kamel, A Ali, M Fouda, ...
Virology 563, 74-81, 2021
152021
Laboratory biomarker predictors for disease progression and outcome among Egyptian COVID-19 patients
LA Fathalla, LM Kamal, O Salaheldin, MA Khalil, MM Kamel, HH Fahim, ...
International Journal of Immunopathology and Pharmacology 36, 03946320221096207, 2022
62022
Thrombophilic mutations and risk of vascular complications in sickle cell disease
MF Sokkar, L Kamal, N Salama, M Hamdy
Gene Reports 27, 101595, 2022
12022
MBL2 gene variants and susceptibility to meningitis in Egyptian patients
MF Sokkar, RM Mosaad, M Khalil, L Kamal
Gene 872, 147442, 2023
2023
The system can't perform the operation now. Try again later.
Articles 1–7